Viewing Study NCT06172205


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-07-06 @ 3:22 AM
Study NCT ID: NCT06172205
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2023-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None BCLC Stage C Hepatocellular Carcinoma View
None Chemotherapy Effect View
Keywords: